Literature DB >> 10619489

Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.

K Abdul-Wahab1, D Corcoran, A Perachiotti, P D Darbre.   

Abstract

Previous transfection experiments using a zinc-inducible expression vector have shown that overexpression of insulin-like growth factor II (IGFII) in MCF7 human breast cancer cells can reduce dependence on oestrogen for cell growth in vitro (DALY RJ, HARRIS WH, WANG DY, DARBRE PD. (1991) Cell Growth Differentiation 2, 457-464.). Parallel transfections now performed into another oestrogen-dependent human breast cancer cell line (ZR-75-1) yielded three clones of transfected ZR-75-1 cells that produced levels of zinc-inducible IGFII mRNA and secreted mature IGFII protein similar to those found in the transfected MCF7 cells. However, unlike in MCF7 cells, no resulting effects were found on cell growth in the ZR-75-1 clones, even though the ZR-75-1 clones possessed receptors capable of binding 125I-IGFI and showed a growth response to exogenously added IGFII. Medium conditioned by the ZR-75-1 clones could stimulate growth of untransfected MCF7 cells, indicating that the secreted IGFII protein was bioactive. Furthermore, zinc-induced IGFII was capable of increasing both pS2 mRNA levels and CAT activity from a transiently transfected AP1-CAT gene in the ZR-75-1 clones. Constitutive co-overexpression of the protein processing enzyme PC2 resulted in reduced levels of large forms of zinc-inducible IGFII, but zinc treatment still produced no effect on cell growth rate. Finally, however, constitutive co-overexpression of the type I IGF receptor (IGFIR) did result in zinc-inducible increased basal cell growth and reduced dependence on oestrogen for cell growth. These results demonstrate that while overexpression of IGFII per se was sufficient to deregulate MCF7 cell growth, the ZR-75-1 cells are limited in their proliferative response by their intrinsic receptor levels. However, although the proliferative response was limited, molecular responses (expression of pS2 and AP1-CAT) were not limited, indicating that different cellular responses can have different threshold receptor level requirements.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619489      PMCID: PMC6726338          DOI: 10.1046/j.1365-2184.1999.3250271.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  52 in total

1.  Differential regulation of two genes implicated in fish reproduction: vitellogenin and estrogen receptor genes.

Authors:  G Flouriot; F Pakdel; B Ducouret; Y Ledrean; Y Valotaire
Journal:  Mol Reprod Dev       Date:  1997-11       Impact factor: 2.609

Review 2.  IGF system components as prognostic markers in breast cancer.

Authors:  A V Lee; S G Hilsenbeck; D Yee
Journal:  Breast Cancer Res Treat       Date:  1998-02       Impact factor: 4.872

3.  Stromal IGF-II messenger RNA in breast cancer: relationship with progesterone receptor expressed by malignant epithelial cells.

Authors:  C Giani; A Pinchera; A Rasmussen; P Fierabracci; R Bonacci; D Campini; G Bevilacqua; B Trock; M E Lippman; K J Cullen
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

4.  A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells.

Authors:  M J Sleigh
Journal:  Anal Biochem       Date:  1986-07       Impact factor: 3.365

5.  The insulin-like growth factors and breast cancer--revisited.

Authors:  D Yee
Journal:  Breast Cancer Res Treat       Date:  1998-02       Impact factor: 4.872

6.  Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2.

Authors:  S P Smeekens; D F Steiner
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

7.  Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism.

Authors:  J A McCubrey; L S Steelman; M W Mayo; P A Algate; R A Dellow; M Kaleko
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

8.  Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism.

Authors:  C A Conover
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

9.  Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition.

Authors:  D R Soprano; L X Chen; S Wu; A M Donigan; R C Borghaei; K J Soprano
Journal:  Oncogene       Date:  1996-02-01       Impact factor: 9.867

10.  Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells.

Authors:  Y Itoh; R N Germain
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.